日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study

基于Tysabri®（那他珠单抗）妊娠暴露登记数据的妊娠结局评估：一项全球性观察性随访研究

期刊:BMC Neurology
影响因子:2.2
doi:10.1186/s12883-016-0674-4
Friend, Susan; Richman, Sandra; Bloomgren, Gary; Cristiano, Lynda M; Wenten, Madé
发表日期：2016
文献求助 收藏

Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy

纳他珠单抗相关进行性多灶性白质脑病生存和功能结局的预测因素

期刊:Journal of Neurovirology
影响因子:1.9
doi:10.1007/s13365-015-0316-4
Dong-Si, Tuan; Gheuens, Sarah; Gangadharan, Amy; Wenten, Made; Philip, Jeffrey; McIninch, James; Datta, Shoibal; Richert, Nancy; Bozic, Carmen; Bloomgren, Gary; Richman, Sandra; Weber, Thomas; Clifford, David B
神经科学
发表日期：2015
文献求助 收藏

Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy

血清或血浆中抗JC病毒抗体水平可进一步确定那他珠单抗相关进行性多灶性白质脑病的风险。

期刊:Annals of Neurology
影响因子:7.7
doi:10.1002/ana.24286
Plavina, Tatiana; Subramanyam, Meena; Bloomgren, Gary; Richman, Sandra; Pace, Amy; Lee, Sophia; Schlain, Brian; Campagnolo, Denise; Belachew, Shibeshih; Ticho, Barry
微生物学
神经科学
发表日期：2014
文献求助 收藏

Outcome and survival of asymptomatic PML in natalizumab-treated MS patients

接受那他珠单抗治疗的多发性硬化症患者中无症状进行性多灶性白质脑病的预后和生存情况

期刊:Annals of Clinical and Translational Neurology
影响因子:3.9
doi:10.1002/acn3.114
Dong-Si, Tuan; Richman, Sandra; Wattjes, Mike P; Wenten, Made; Gheuens, Sarah; Philip, Jeffrey; Datta, Shoibal; McIninch, James; Bozic, Carmen; Bloomgren, Gary; Richert, Nancy
神经科学
多发性硬化症
发表日期：2014
文献求助 收藏

Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti-diabetic medication: a follow-up study

与使用其他抗糖尿病药物的患者相比，每日两次使用艾塞那肽的患者发生急性胰腺炎的相对风险：一项随访研究

期刊:Diabetic Medicine
影响因子:3.4
doi:10.1111/j.1464-5491.2012.03652.x
Wenten, M; Gaebler, J A; Hussein, M; Pelletier, E M; Smith, D B; Girase, P; Noel, R A; Braun, D K; Bloomgren, G L
代谢
糖尿病
胰腺炎
发表日期：2012
文献求助 收藏

Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data

利用健康保险索赔数据库和上市后监测数据对接受肌注干扰素β-1a治疗的多发性硬化症患者的恶性肿瘤风险进行回顾性评估

期刊:Therapeutics and Clinical Risk Management
影响因子:2.2
doi:10.2147/TCRM.S31347
Bloomgren, Gary; Sperling, Bjørn; Cushing, Kimberly; Wenten, Madé
神经科学
肿瘤
肿瘤免疫
多发性硬化症
发表日期：2012
文献求助 收藏